Business description
SYNLAB Group is the largest European clinical laboratory and medical diagnostic services provider by revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
Management board & Supervisory board
| CEO |
| Mathieu Floreani |
| Management board |
| Sami Badarani, Robert Steinwander, Dr Santiago Valor, Luis Vieira, Henrik Andreasen, Catharina Monster, Dr Fabian Walla |
| Supervisory board |
| Prof Dr David Ebsworth, Barbara Lambert, Dr Bartl Wimmer, Alex Leslie, Anastasya Molodykh-McFarlane, Christian Salling, Karin Bierstedt, Dr Stefan Graf, Dr Ute Hasholzner, Rene Schmidt-Ferroud, Marc Welters, Iris Schopper |
Company data
| Name: |
SYNLAB AG |
| Address: |
Moosacher Straße 88,D-80809 München |
| Phone: |
+49-89-307-602-0 |
| Fax: |
- |
| E-mail: |
info@synlab.com
|
| Internet: |
https://www.synlab.de/ |
| Industry: |
Healthcare |
| Sector: |
Healthcare Providers |
| Sub sector: |
Healthcare Providers |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
- |
| IR phone: |
+49 89 307602-0 |
| IR Fax: |
- |
| IR e-mail: |
ir@synlab.com
|
